Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention
Clinical trial NCT04686773 · COMPLETED
Trial details
- NCT number
- NCT04686773
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2021-10-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.